A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Parameswaran Hari, Omar S. Aljitawi, Carlos Arce-Lara, Rajneesh Nath, Natalie Callander, Gajanan Bhat, Lee F. Allen, Keith Stockerl-Goldstein
Dive into the research topics of 'A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation'. Together they form a unique fingerprint.